Generex Biotechnology Corp. (fka GNBTQ)

[WeeZuhl]

Molecular Biology Porn


This is hot!!

The blood screening program, which is scheduled to begin next week, incorporates T Cell Assays, antibody screening and isolation, virus neutralization tests (PRNT – Plaque Reduction Neutralization Test), and a novel in-vitro “cytokine storm” cellular assay. Through this proprietary method, Generex can identify the Ii-Key-SARS-CoV-2 peptides vaccines most likely to stimulate the appropriate T-Cell (CD4 and CD8) responses and modulate the correct immune system responses to minimize potential for dysregulated cytokine-related inflammation, stimulate a neutralizing antibody response, with the goal of providing a broad-spectrum coverage for the vast majority of people. This strategy leverages Ii-Key technology to develop a “Complete Vaccine” that has the potential to induce the likelihood of protective immunity with long-lasting immunologic memory against SARS-COV-2 in a highly specific manner to ensure safety.

Separating the true scientists at Antigen from the true dufuses (dufi?) at Generex is overdue by at least five years. We can only hope the leaders at Antigen will have true independence from the perpetual penny-stockers at Generex.